Article

FDA clears use of Opti-Free replenish with SynergEyes contact lenses

Carlsbad, CA-SynergEyes Inc. has received FDA market clearance for the use of Alcon Opti-Free Replenish multi-purpose disinfecting solution with SynergEyes contact lenses.

Carlsbad, CA-SynergEyes Inc. has received FDA market clearance for the use of Alcon Opti-Free Replenish multi-purpose disinfecting solution with SynergEyes contact lenses.

According to SynergEyes co-founder and Chief Technology Officer Jerry Legerton, OD, FAAO, "Opti-Free Replenish proved to be compatible with our HydrolEyes surface science and complements our materials on eye. The care product requirements for the combination of hydrophilic and hydrophobic surface groups in our hybrid lens are similar to the requirements for silicone hydrogel lenses."

SynergEyes manufactures a new type of contact lens that combines two materials, a rigid gas permeable center and a soft, hydrophilic outer skirt. The result is a durable "hybrid" lens for patients seeking crisp, clear vision and the all-day comfort of a soft lens.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
(Image credit: Ophthalmology Times) The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD
(Image credit: Ophthalmology Times) AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
© 2025 MJH Life Sciences

All rights reserved.